Arcus Biosciences Inc (RCUS)
15.55
+0.82
(+5.57%)
USD |
NYSE |
Apr 26, 16:00
15.56
0.00 (0.00%)
Pre-Market: 20:00
Arcus Biosciences Free Cash Flow (Quarterly): -94.00M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -94.00M |
| September 30, 2023 | -73.00M |
| June 30, 2023 | -62.00M |
| March 31, 2023 | -101.00M |
| December 31, 2022 | -70.00M |
| September 30, 2022 | -83.00M |
| June 30, 2022 | -72.00M |
| March 31, 2022 | 651.00M |
| December 31, 2021 | -70.36M |
| September 30, 2021 | -61.62M |
| June 30, 2021 | -80.07M |
| March 31, 2021 | -69.96M |
| December 31, 2020 | -51.51M |
| September 30, 2020 | 215.19M |
| Date | Value |
|---|---|
| June 30, 2020 | -24.19M |
| March 31, 2020 | -31.49M |
| December 31, 2019 | -9.667M |
| September 30, 2019 | -27.95M |
| June 30, 2019 | -20.30M |
| March 31, 2019 | -17.47M |
| December 31, 2018 | -7.365M |
| September 30, 2018 | -12.89M |
| June 30, 2018 | -12.18M |
| March 31, 2018 | -14.30M |
| December 31, 2017 | 15.29M |
| September 30, 2017 | -25.07M |
| June 30, 2017 | -9.057M |
| March 31, 2017 | -11.74M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-101.00M
Minimum
Mar 2023
651.00M
Maximum
Mar 2022
-7.154M
Average
-62.00M
Median
Jun 2023
Free Cash Flow (Quarterly) Benchmarks
| Gilead Sciences Inc | 1.954B |
| Catalyst Pharmaceuticals Inc | 53.33M |
| Integra Lifesciences Holdings Corp | 34.22M |
| Palatin Technologies Inc | -10.51M |
| Petros Pharmaceuticals Inc | -2.260M |